COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - BIO-TECHNE CORP ownership

BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 254 filers reported holding BIO-TECHNE CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

About BIO-TECHNE CORP

Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.

Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.

In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.

Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.

Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of BIO-TECHNE CORP
ValueSharesWeighting
Q2 2024$2,480,093
+2.1%
34,614
+0.3%
0.02%
-5.9%
Q1 2024$2,429,018
-9.1%
34,508
-0.4%
0.02%
-10.5%
Q4 2023$2,672,282
+24.0%
34,633
+9.4%
0.02%
+5.6%
Q3 2023$2,154,824
-3.9%
31,656
+15.3%
0.02%0.0%
Q2 2023$2,241,397
+13.3%
27,458
+3.0%
0.02%
+5.9%
Q1 2023$1,978,054
+89852.4%
26,662
+0.5%
0.02%
-10.5%
Q4 2022$2,199
-99.9%
26,533
+362.3%
0.02%
+18.8%
Q3 2022$1,630,000
-17.7%
5,739
+0.5%
0.02%
-23.8%
Q2 2022$1,980,000
-13.0%
5,712
+8.7%
0.02%
-4.5%
Q1 2022$2,276,000
-10.8%
5,257
+6.6%
0.02%
-18.5%
Q4 2021$2,552,000
+8.0%
4,932
+1.2%
0.03%0.0%
Q3 2021$2,362,000
-59.5%
4,874
-62.4%
0.03%
-58.5%
Q2 2021$5,834,000
+18.0%
12,956
+0.1%
0.06%
+6.6%
Q1 2021$4,944,000
+20.8%
12,944
+0.4%
0.06%
+5.2%
Q4 2020$4,094,000
+33.7%
12,893
+4.4%
0.06%
-3.3%
Q3 2020$3,061,000
+43.4%
12,355
+52.8%
0.06%
+50.0%
Q2 2020$2,135,000
+25.6%
8,086
-9.8%
0.04%
+2.6%
Q1 2020$1,700,000
+15.2%
8,966
+33.4%
0.04%
+50.0%
Q4 2019$1,476,000
+12.6%
6,722
+0.3%
0.03%
+13.0%
Q3 2019$1,311,000
-5.8%
6,702
+0.4%
0.02%
-4.2%
Q2 2019$1,391,000
+5.3%
6,674
+0.3%
0.02%
+4.3%
Q1 2019$1,321,000
+37.7%
6,653
+0.4%
0.02%
+21.1%
Q4 2018$959,000
-38.7%
6,627
-13.6%
0.02%
-13.6%
Q3 2018$1,565,000
+4.3%
7,666
-24.4%
0.02%
+10.0%
Q2 2018$1,501,000
-1.6%
10,142
+0.4%
0.02%
-4.8%
Q1 2018$1,526,000
+115.2%
10,104
+84.6%
0.02%
+110.0%
Q4 2017$709,000
+7.8%
5,472
+0.5%
0.01%0.0%
Q3 2017$658,000
+2.8%
5,446
-0.1%
0.01%0.0%
Q2 2017$640,000
+15.5%
5,449
-0.0%
0.01%
+11.1%
Q1 2017$554,000
-2.5%
5,450
-1.3%
0.01%
-18.2%
Q4 2016$568,000
-6.0%
5,524
+0.1%
0.01%
-8.3%
Q3 2016$604,000
-25.2%
5,517
-23.0%
0.01%
-20.0%
Q2 2016$808,000
+28.7%
7,163
+7.7%
0.02%
+15.4%
Q1 2016$628,000
-35.3%
6,648
-38.3%
0.01%
-35.0%
Q4 2015$970,000
-2.2%
10,783
+0.5%
0.02%
-16.7%
Q3 2015$992,000
-6.1%
10,730
-0.0%
0.02%
+26.3%
Q2 2015$1,057,000
+8.7%
10,734
+10.8%
0.02%
+11.8%
Q1 2015$972,000
+32.2%
9,691
+21.9%
0.02%
+54.5%
Q4 2014$735,0007,9530.01%
Other shareholders
BIO-TECHNE CORP shareholders Q4 2014
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 46,500$13,206,0005.33%
Montanaro Asset Management Ltd 101,950$28,954,0004.43%
Jackson Square Partners, LLC 521,991$148,245,0003.89%
Sandhill Capital Partners LLC 119,671$33,987,0003.88%
STONE RUN CAPITAL, LLC 22,055$6,264,0003.38%
Ownership Capital B.V. 610,466$173,372,0003.35%
Brown Capital Management 823,303$233,818,0003.28%
DF DENT & CO INC 671,348$190,663,0002.94%
Westwind Capital 27,931$7,932,0002.78%
MAIRS & POWER INC 673,620$191,308,0002.41%
View complete list of BIO-TECHNE CORP shareholders